CONTACT
Evrota 25-27, Kifisia 145 64
+30 2111021821
info@idnagenomics.com
ΓΕΜΗ 152515201000
Our Scientific Advisors
Our team consists of PhDs specializing in genetics, molecular biology, biochemistry, nutrition genetics and bioinformatics. The combined skill set of the team allows us to analyze the latest scientific literature and develop appropriate training and nutrition protocols. We also have valuable collaborations with doctors of many specialties as well as with the academic community.
Apostolos “Paul” Psychogios
Scientific Advisor, Medical Geneticist, MD, DABMG, Fellow of the American College of Medical Genetics and Genomics (FACMG)
Learn more
Dr. Nikolaos Drakoulis
MD, PhD, Prof. Professor of Clinical Pharmacology at University of Athens, School of Health Sciences, Faculty of Pharmacy
Learn more
Dr. Nikolaos Spanakis
PhD, Associate Professor of Microbiology University of Athens and Managing Director at A-LAB of HHG Group
Learn more
Apostolos “Paul” Psychogios, MD, FACMG
Dr. Apostolos “Paul” Psychogios is an American Board of Medical Genetics and Genomics (ABMGG) certified clinical geneticist and a Fellow of the American College of Medical Genetics and Genomics (FACMG). In May 2023, he started working as Executive Medical Director at genomeoneclinic.com, a company that provides online medical genetics and genomics services. He is the founder of Genome 1st a genome health and precision medicine company (February 2022). Dr. Psychogios completed his residency in medical and clinical genetics at Columbia University Medical Center in New York City and his fellowship in clinical molecular genetics at Harvard Medical School in Boston.
He served as the Chief of Genetics at Dayton Children’s in Dayton, Ohio (2020-2022) and the Chief of Genetics and Metabolism at the Kentucky Children’s in Lexington, KY (2020). He founded the first cardiovascular genetics and genomics service in Kentucky at the UK Gill Heart & Vascular Institute. Dr. Psychogios had previously practiced and held academic appointments in Mayo Clinic, Vanderbilt University Medical Center, and Cleveland Clinic. Before coming to the US, he practiced cardiology in the United Kingdom. He has more than 30 years of clinical experience in internal medicine, cardiology, medical genetics, clinical molecular genetics, and genomic medicine with emphasis in the diagnosis, management, and prevention of heritable disorders and complex undiagnosed conditions in children and adults.
Current practice, areas of interest, and expertise
1. Pediatric, adult genetics, rare and common disorders, undiagnosed disorders, complex familial conditions, with emphasis on pediatric, cancer, psychiatric, cardiovascular, renal genetics and genomics, and pharmacogenetics
2. Transplantation genetics and genomics
3. Orphan drugs, rare disorders, inborn errors of metabolism
4. Whole genome sequencing as a first test in the clinic and urgent care (NICU)
5. Provider-enabled reanalysis of nondiagnostic exome or genome
6. Precision care throughout lifetime (prevention of chronic disease from birth to end of life)
Dr. Psychogios’ practice focuses on promoting precision medicine and health by leveraging genome sequencing and AI/ML technologies. He has been offering Whole Genome Sequencing (WGS) as a first test in the clinic since January 2018 with a combined diagnostic yield of 71% (2022 ACMG Meeting).
Selected recent articles, posters, and presentations
1. Psychogios, A., Trachana, K. Genome Sequencing as a First Tier in the Clinic, eP219 2022 ACMG Annual Clinical Genetics Meeting, Nashville March 22-26
2. Psychogios, A., Roumeliotis, G., Trachana, K., Hood, Leroy. One Stone, Two Birds: How a WGS enabled Diagnostic Journey Transforms into a Precision Population Health Service for the 21st Century. 2021 ACMG Annual Clinical Genetics Meeting, April 13-16
Dr. Nikolaos Drakoulis, MD, PhD
Born in Piraeus Greece he studied Biochemistry at the University of Tubingen and Medicine at the Freie Universirät Berlin, Germany.
He received his PhD at the University of Berlin and specialized in Clinical and Molecular Genetics, in Human Pharmacoepidemiology, in Clinical Pharmacology and Clinical Chemistry.
Worked at the Institutes of Clinical Pharmacology and Human Genetics, Freie Universirät Berlin and Charite University Berlin.
Professor of Pharmacology and Clinical Pharmacology at University of Athens, School of Health Sciences, Faculty of Pharmacy since 2001, teaching Pharmacology, Clinical Pharmacology and Pharmacogenetics.
Member of numerous scientific committees, boards and societies, president of the Hellenic Society of Pharmacogenomics and Personalized Diagnosis and Therapy (EEPHARM).
Head of Research Group of Clinical Pharmacology and Pharmacogenomics, University of Athens.
Dr. Nikolaos Spanakis, PhD
Dr. Nikolaos Spanakis was born in Athens, studied at the Biology Department of the School of Science, Univerity of Athens and wrote his thesis at the Molecular Oncology and Biotechnology Lab of the National Hellenic Research Foundation. After that, he completed his Medicine studies and wrote his thesis at the Histology and Embryology Lab of Medical School, University of Athens.
Since 2005 he has been the Director of the Virology Unit at the Microbiology Lab of Medical School, University of Athens, where he also teaches as an associate professor. From
2009 he was successfully managing the Molecular Biology and Genetics Lab of Metropolitan Hospital and after that he took over the General Management of AlphaLab S.A., a member of Hygeia Group, as the Head of Molecular Biology department. He was Quality Management Officer and after that Manager of the Molecular Biology and Microbiology Labs at the Medical Analysis LTD in Athens, whereas he also worked at the Nephrology Centre of Hygeia Hospital and as a researcher at the Virology Unit of Microbiology Lab of Medical School, University of Athens, as well as at the Endocrinology Department research laboratory of the 1st Department of Pathology, Medical School, University of Athens.
His research interest is Virology and Molecular Microbiology, whereas, he has accomplished 60 international research dissertations, as well as numerous lectures and presentations in national and global congresses and he has also completed translations of medical publications on Microbiology topics.